Rediscovering the octapeptins.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Natural product reports (Print)

• Publication date

  2017-03-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1039/c6np00113kPMID 28180225PMCID PMC5802877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?

  2018cited by this paper
• The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs

  2018cited by this paper
• Alternative Biosynthetic Starter Units Enhance the Structural Diversity of Cyanobacterial Lipopeptides

  2018cited by this paper
• Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate

  2018cited by this paper
• The antibiotic resistance crisis: part 1: causes and threats.

  2015cited by this paper
• Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.

  2015cited by this paper
• Antibiotic resistance threats in the United States: stepping back from the brink.

  2014cited by this paper
• A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity

  2013cited by this paper
• Efficient Production of Polymyxin in the Surrogate Host Bacillus subtilis by Introducing a Foreign ectB Gene and Disrupting the abrB Gene

  2012cited by this paper
• Overcoming the challenges to developing new antibiotics.

  2012cited by this paper
• Battacin (Octapeptin B5), a New Cyclic Lipopeptide Antibiotic from Paenibacillus tianmuensis Active against Multidrug-Resistant Gram-Negative Bacteria

  2011cited by this paper
• Structure--activity relationships of polymyxin antibiotics.

  2010cited by this paper
• Identification of a Polymyxin Synthetase Gene Cluster of Paenibacillus polymyxa and Heterologous Expression of the Gene in Bacillus subtilis

  2009cited by this paper
• The natural history of antibiotics.

  2009cited by this paper
• Involvement of pmrAB and phoPQ in Polymyxin B Adaptation and Inducible Resistance in Non-Cystic Fibrosis Clinical Isolates of Pseudomonas aeruginosa

  2009cited by this paper
• Multidrug resistance in bacteria.

  2009cited by this paper
• The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more.

  2008cited by this paper
• Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents

  2008cited by this paper
• Emergence of Multidrug Resistance in Bacteria and Impact on Antibiotic Expenditure at a Major Army Medical Center Caring for Soldiers Wounded in Iraq and Afghanistan

  2008cited by this paper
• Chemical structure and immunobiological activity of lipid A from Serratia marcescens LPS.

  2007cited by this paper
• Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

  2006cited by this paper
• PhoP‐regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B

  2004cited by this paper
• Molecular Basis of Bacterial Outer Membrane Permeability Revisited

  2003cited by this paper
• Non-ribosomal peptide synthetases as technological platforms for the synthesis of highly modified peptide bioeffectors--Cyclosporin synthetase as a complex example.

  2003cited by this paper
• Multidrug resistance in Gram-negative bacteria.

  2001cited by this paper
• An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor.

  2001cited by this paper
• Wonder drugs: a history of antibiotics.

  2001cited by this paper
• Genetic and Functional Analysis of a PmrA-PmrB-Regulated Locus Necessary for Lipopolysaccharide Modification, Antimicrobial Peptide Resistance, and Oral Virulence of Salmonella entericaSerovar Typhimurium

  2000cited by this paper
• Multidrug resistance in lactic acid bacteria: molecular mechanisms and clinical relevance

  1999cited by this paper
• Cationic peptides: a new source of antibiotics.

  1998cited by this paper
• PmrA–PmrB‐regulated genes necessary for 4‐aminoarabinose lipid A modification and polymyxin resistance

  1998cited by this paper
• Peptide antibiotics.

  1997cited by this paper
• Antibacterial peptides and the outer membranes of gram-negative bacilli.

  1997cited by this paper
• The bacterial outer membrane as a drug barrier.

  1997cited by this paper
• The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.

  1991cited by this paper
• Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium

  1987cited by this paper
• The history of antibiotics: a critical bibliography.

  1986cited by this paper
• Susceptibility of gram-negative bacteria to polymyxin B nonapeptide

  1984cited by this paper
• Bu-2470, a new peptide antibiotic complex. I. Production, isolation and properties of Bu-2470 A, B1 and B2.

  1983cited by this paper
• Bu-2470, A NEW PEPTIDE ANTIBIOTIC COMPLEX

  1983cited by this paper
• Bu-2470, a new peptide antibiotic complex. II. Structure determination of Bu-2470 A, B1, B2a and B2b.

  1983cited by this paper
• Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant.

  1983cited by this paper
• Carbon-13 NMR studies of EM 49 and related octapeptins.

  1980cited by this paper
• Isolation of octapeptin D (studies on antibiotics from the genus Bacillus. XXVII).

  1980cited by this paper
• The structure of octapeptin D (studies on antibiotics from the genus Bacillus. XXVIII).

  1980cited by this paper
• Characterization of octapeptin-membrane interactions using spin-labeled octapeptin.

  1980cited by this paper
• Mechanism of Action of EM 49, Membrane-Active Peptide Antibiotic

  1977cited by this paper
• Polymyxin and related peptide antibiotics.

  1977cited by this paper
• Inhibition of Escherichia coli growth and respiration by polymyxin B covalently attached to agarose beads.

  1977cited by this paper
• The constituent amino acids and fatty acid of antibiotic 333-25. (Studies on antibiotics from the genus Bacillus. XII.

  1976cited by this paper
• Isolation of a new antibiotic 333-25, related to antibiotic EM 49. (Studies on antibiotics from the genus Bacillus. XI).

  1976cited by this paper
• A nomenclature proposal for the octapeptin antibiotics.

  1976cited by this paper
• Disruption of Escherichia coli outer membranes by EM 49. A new membrane active peptide.

  1976cited by this paper
• EM49, a new peptide antibiotic IV. The structure of EM49.

  1975cited by this paper
• EM49: A NEW POLYPEPTIDE ANTIBIOTIC ACTIVE AGAINST CELL MEMBRANES

  1974cited by this paper
• EM49, a new peptide antibiotic. I. Fermentation, isolation, and preliminary characterization.

  1973cited by this paper
• EM49, a new peptide antibiotic. II. Chemical characterization.

  1973cited by this paper
• EM49, a new peptide antibiotic. 3. biological characterization in vitro and in vivo.

  1973cited by this paper
• EM49, A NEW PEPTIDE ANTIBIOTIC&

  1973cited by this paper
• Electron microscopic studies on mode of action of polymyxin

  1969cited by this paper
• Antimicrobial Agents and Chemotherapy

  1969cited by this paper

• Engineering the biosynthesis of natural lipopeptide octapeptins in Paenibacillus elgii 219 to combat multidrug-resistant

  2025cites this paper
• Antimicrobial Peptides in Focus: Functional Potential and Translational Evidence from Swine Systems

  2025cites this paper
• Recent Advances in the Development of Polymyxin Antibiotics: 2010–2023

  2024cites this paper
• Differential MRGPRX2-dependent activation of human mast cells by polymyxins and octapeptins.

  2024cites this paper
• The Effects of Octapeptin Supplementation on Growth Performance, Serum Biochemistry, Serum Immunity, and Gut Microbiota in Weaned Piglets

  2024cites this paper
• A review on mechanisms and prospects of endophytic bacteria in biocontrol of plant pathogenic fungi and their plant growth-promoting activities

  2024cites this paper
• Design, Synthesis, and Bioactivity Investigation of Cyclic Lipopeptide Antibiotics Containing Eight to Nine Amino Acids.

  2023cites this paper
• How to treat severe Acinetobacter baumannii infections

  2023cites this paper
• Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides.

  2023cites this paper
• Acinetobacter Baumannii Phages: Past, Present and Future

  2023cites this paper
• Purification, structure and characterization of the novel antimicrobial lipopeptides produced by Paenibacillus ehimensis HD

  2023cites this paper
• Man vs Microbes - The Race of the Century.

  2023cites this paper
• Short Peptides and Their Mimetics as Potent Antibacterial Agents and Antibiotic Adjuvants.

  2021cites this paper
• Fusaricidins, Polymyxins and Volatiles Produced by Paenibacillus polymyxa Strains DSM 32871 and M1

  2021cites this paper
• Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities

  2021cites this paper
• Characterization of a novel antifungal protein produced by Paenibacillus polymyxa isolated from the wheat rhizosphere.

  2020cites this paper
• How do cyclic antibiotics with activity against Gram-negative bacteria permeate membranes? A machine learning informed experimental study.

  2020cites this paper
• Strategic Moves of "Superbugs" Against Available Chemical Scaffolds: Signaling, Regulation, and Challenges.

  2020cites this paper
• Simulations of octapeptin–outer membrane interactions reveal conformational flexibility is linked to antimicrobial potency

  2020cites this paper
• Molecular Dynamics Simulation of the Interaction of Two Linear Battacin Analogs with Model Gram-Positive and Gram-Negative Bacterial Cell Membranes

  2020cites this paper
• Characterization of Paenibacillus pabuli and its antibacterial activity against Gram-negative bacteria

  2019cites this paper
• Battacin-Inspired Ultrashort Peptides: Nanostructure Analysis and Antimicrobial Activity.

  2019cites this paper
• Sugar γ‐Amino Acids as Building Blocks for the Synthesis of Cyclic Neoglycopeptides.

  2018cites this paper
• Octapeptin C4 Induces Less Resistance and Novel Mutations in an Epidemic Carbapenemase-producing Klebsiella pneumoniae ST258 Clinical Isolate Compared to Polymyxins

  2018cites this paper
• New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin B and colistin

  2018cites this paper
• Alternative Biosynthetic Starter Units Enhance the Structural Diversity of Cyanobacterial Lipopeptides

  2018cites this paper
• Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate

  2018cites this paper
• 4-Chloro-l-kynurenine as fluorescent amino acid in natural peptides

  2018cites this paper
• Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?

  2018cites this paper
• The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs

  2018cites this paper
• Genome Mining of the Lipopeptide Biosynthesis of Paenibacillus polymyxa E681 in Combination with Mass Spectrometry: Discovery of the Lipoheptapeptide Paenilipoheptin

  2018cites this paper
• Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species

  2017cites this paper
• Recent advances and perspectives in the design and development of polymyxins.

  2017cites this paper
• Drug-target interactions that involve the replacement or displacement of magnesium ions.

  2017influential citation
• Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.

  2017cites this paper
• Targeting microbial biofilms: current and prospective therapeutic strategies

  2017cites this paper